Publications

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

Hepatocellular carcinoma

European Position Paper on Rhinosinusitis and Nasal Polyps 2020

The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objecti...

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

This study describes results of PCR and viral RNA testing for SARS-CoV-2 in bronchoalveolar fluid, sputum, feces, blood, and urine specimens from patients with COVID-19 infectio...

TIMER2.0 for analysis of tumor-infiltrating immune cells

Abstract Tumor progression and the efficacy of immunotherapy are strongly influenced by the composition and abundance of immune cells in the tumor microenvironment. Due to the l...

Characteristics of SARS-CoV-2 and COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute re...

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Impact of COVID-19 pandemic on mental health in the general population: A systematic review

Clinical and Laboratory Standards Institute

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells